Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Protein Networks02:26

Protein Networks

3.7K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
3.7K
Protein Networks02:26

Protein Networks

1.8K
1.8K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.9K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.9K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

8.3K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
8.3K
Drug toxicity: Drug–Drug Interaction01:30

Drug toxicity: Drug–Drug Interaction

423
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
423
Drug-Receptor Bonds01:25

Drug-Receptor Bonds

4.8K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
4.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Novel DRD2 Antagonist, SD2-2305, Exerts Anticancer Effects in Colorectal Cancer Cells through G1 Arrest and Caspase-Dependent Apoptosis.

Biomolecules & therapeutics·2026
Same author

Ginsenoside Rd attenuates renal aging and fibrosis through inhibition of angiotensin II type 1 receptor signaling.

Phytomedicine : international journal of phytotherapy and phytopharmacology·2026
Same author

A Modularized Higher-Order Diagnostic Classification Model for Clustered Attribute Hierarchies.

Multivariate behavioral research·2026
Same author

AOP Network Box: An Integrative Framework for Bridging Adverse Outcome Pathways and Biological Networks.

Chemical research in toxicology·2026
Same author

Uncovering Hierarchical Asymmetries in Artificial Intelligence Transformation: Navigating the Bright and Dark Sides Across Organizational Levels.

Journal of visualized experiments : JoVE·2026
Same author

PPS03 triggers cancer-selective necroptosis in hepatocellular carcinoma via macropinocytosis-dependent ROS overload.

Biomaterials·2026
Same journal

Correction to: A quantitative systems pharmacology (QSP) model for Pneumocystis treatment in mice.

BMC systems biology·2019
Same journal

Predicting disease-related phenotypes using an integrated phenotype similarity measurement based on HPO.

BMC systems biology·2019
Same journal

Fusing gene expressions and transitive protein-protein interactions for inference of gene regulatory networks.

BMC systems biology·2019
Same journal

A fast and efficient count-based matrix factorization method for detecting cell types from single-cell RNAseq data.

BMC systems biology·2019
Same journal

GNE: a deep learning framework for gene network inference by aggregating biological information.

BMC systems biology·2019
Same journal

FCMDAP: using miRNA family and cluster information to improve the prediction accuracy of disease related miRNAs.

BMC systems biology·2019
See all related articles

Related Experiment Video

Updated: May 2, 2026

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
13:18

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

1.9K

Interaction network among functional drug groups.

Minho Lee, Keunwan Park, Dongsup Kim

    BMC Systems Biology
    |February 22, 2014
    PubMed
    Summary
    This summary is machine-generated.

    This study introduces a novel network-based approach to analyze drug interactions by grouping drugs based on their function. This method reveals insights into drug group interactions, aiding in understanding drug mechanisms and features.

    Related Experiment Videos

    Last Updated: May 2, 2026

    Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
    13:18

    Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

    Published on: March 3, 2023

    1.9K

    Area of Science:

    • Pharmacology
    • Computational Biology
    • Network Science

    Background:

    • Growing interest in drug combinatorial effects for complex diseases and avoiding adverse drug interactions.
    • Need for systematic and intuitive analysis of accumulated drug interaction data.

    Purpose of the Study:

    • To develop a network-based method for analyzing interactions between functional drug groups.
    • To provide intuitive interpretations of drug group interactions.

    Main Methods:

    • Functional drug groups were defined using the Anatomical Therapeutic Chemical (ATC) Classification System.
    • Interaction networks of drug groups were constructed based on defined relatedness criteria.
    • A second network was built using an interaction sharing ratio from the first network.

    Main Results:

    • The constructed networks offer intuitive insights into drug group interactions.
    • Analysis revealed that drug features can be described by these interactions, even for structurally dissimilar drugs.
    • The approach effectively visualizes relationships beyond individual drug-drug interactions.

    Conclusions:

    • The developed networks provide novel insights into interactions among functional drug groups.
    • This network-based information serves as a valuable resource for understanding drug mechanisms and characteristics.